Banque Cantonale Vaudoise Abb Vie Inc. Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Abb Vie Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 48,408 shares of ABBV stock, worth $8.71 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

48,408

Previous 43,758 10.63%

Holding current value

$8.71 Million

Previous $7.5 Million 27.4%

% of portfolio

0.39%

Previous 0.3%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $761,856 - $926,884	4,650 Added 10.63%	48,408 $9.56 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $1.31 Million - $1.53 Million	-8,486 Reduced 16.24%	43,758 $7.5 Million
Q1 2024 Apr 10, 2024	BUY	$159.82 - $182.1 $1.3 Million - $1.48 Million	8,122 Added 18.41%	52,244 $9.51 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $1.44 Million - $1.62 Million	-10,473 Reduced 19.18%	44,122 $6.84 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $357,353 - $413,688	-2,675 Reduced 4.67%	54,595 $8.14 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $965,865 - $1.2 Million	7,289 Added 14.58%	57,270 $7.72 Million
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $22,848 - $26,313	158 Added 0.32%	49,981 $7.97 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $1.43 Million - $1.71 Million	-10,329 Reduced 17.17%	49,823 $8.05 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $834,249 - $956,828	-6,216 Reduced 9.37%	60,152 $8.07 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $995,680 - $1.27 Million	7,235 Added 12.24%	66,368 $10.2 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $615,950 - $764,221	4,667 Added 8.57%	59,133 $9.58 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.08 Million - $1.37 Million	-10,069 Reduced 15.6%	54,466 $7.38 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $2.8 Million - $3.18 Million	26,359 Added 69.05%	64,535 $6.96 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $2.3 Million - $2.56 Million	-21,874 Reduced 36.43%	38,176 $4.3 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $1.45 Million - $1.6 Million	-14,199 Reduced 19.12%	60,050 $6.5 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $233,018 - $314,599	-2,895 Reduced 3.75%	74,249 $7.96 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $734,874 - $862,499	8,554 Added 12.47%	77,144 $6.76 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $1.12 Million - $1.5 Million	15,258 Added 28.61%	68,590 $6.73 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $335,400 - $508,508	5,200 Added 10.8%	53,332 $4.06 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $3.47 Million - $4.34 Million	48,132 New	48,132 $4.26 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Abb Vie Inc. Transaction History